Next Steps for Clinical Trials and Research Policy in the UK

The GMHCP Journal Club hosted an engaging session on 19 February 2026 at the Jean McFarlane Building, The University of Manchester, with participants joining both in person and online.

The session was presented by Dileep Kumar, Communications Officer at The University of Manchester. He holds a Master’s degree in Public Health (MPH) and a Bachelor’s degree in Pharmacy (BPharm) and is a Fellow of the Royal Society for Public Health (FRSPH), UK. He is also a member of the Royal Society of Tropical Medicine and Hygiene (RSTMH). With over 18 years of experience in public health, health improvement, mental health, and research coordination, Dileep has led and supported multidisciplinary research and health programmes across the UK and several low- and middle-income countries, with a particular focus on strategic communications, implementation, and global health partnerships.

His presentation, “Next Steps for Clinical Trials and Research Policy in the UK,” examined recent developments in the UK clinical research landscape and their implications for the future of health research, policy, and innovation.

Session Summary

The presentation explored emerging priorities for strengthening the UK’s clinical research ecosystem, with a focus on improving the efficiency, inclusivity, and impact of clinical trials. It highlighted recent policy developments designed to streamline research governance, increase participant diversity, accelerate study delivery, and strengthen collaboration between researchers, healthcare providers, industry, and policymakers.

The session also discussed the importance of embedding patient and public involvement, embracing digital innovation, and fostering international research partnerships to ensure that clinical research is more responsive to population health needs. These developments have significant implications for advancing high-quality, equitable, and impactful health research both within the UK and globally. We extend our sincere thanks to Dileep Kumar for sharing his insights and expertise on the evolving clinical research landscape. We also thank everyone who attended, both in person and online, for their active participation and contributions, helping to make the session a great success.